Search results for

The Dow Jones Board, and specifically the Bancroft family, announced Thursday a desire to entertain purchase offers, including one from Rupert Murdoch that will be tough to beat. What would The Wall Street Journal look like if Murdoch, who has a long track record at The Times of London, becomes boss.

President Bush will address the nation Thursday night. He's expected to announce the beginning of a drawdown of U.S. troops from Iraq — including 5,700 troops to be pulled out in December.

Eating the omega-3 fatty acids found in fish has its benefits for the developing brain, but some women are advised to eat only limited amounts due to concerns about mercury. But one lab is cooking up brain food from where fish get it: algae.

Massachusetts Sen. Ted Kennedy has been diagnosed with a malignant glioma, a type of brain cancer. Dr. Andrew Norden of the Dana-Farber Cancer Institute in Boston talks about the treatment and prognosis of malignant gliomas.

In New Orleans, there is a sense of relief that Hurricane Gustav didn't roar ashore as hard as it could have. The city avoided a direct hit, and its improved levee system has held.

The joke used to be that some women went to college to get their M.R.S. — that is, a husband. But a study by the Pew Research Center finds that women today are more likely to marry men who have lower education levels and lower income levels than they do.

News of Ted Stevens' indictment for allegedly failing to disclose services he received from a private company drew mixed reactions from his Senate colleagues. The Alaska senator, who faces seven felony counts, has allies on both sides of the aisle and has declared his innocence.

As states brace for insurance market instability, some — like Maryland — take aggressive action.

After a war of words between President Trump and North Korea's Kim Jong Un over the ability to launch nuclear attacks from their desks, orders rose for pills to protect against radiation.

Food and Drug Commissioner Scott Gottlieb says he wants to know why drugmakers churn out medicines for some rare diseases but not others.